Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Open-Label Single-Arm Study of E7080 (Lenvatinib) in Advanced Endometrial Cancer After First-Line Chemotherapy
2009-016858-41Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenvatinib in endometrial cancer (EC), sponsored by Eisai Co., Ltd. Primary endpoint: Objective tumour response rate. Started Jun 2010; status: completed.
02
Drugs
lenvatinib
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on 2009-016858-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016858-41.